You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

List of Excipients in API glucagon

✉ Email this page to a colleague

« Back to Dashboard

Excipients in NDA-approved (novel) drugs containing glucagon

Subscribe to access the full database, or Subscribe
Company	Tradename	Ingredient	NDC	Excipient	Potential Generic Entry
Eli Lilly and Company	BAQSIMI	glucagon	0002-6145	ACETIC ACID
Eli Lilly and Company	BAQSIMI	glucagon	0002-6145	BETADEX
Eli Lilly and Company	BAQSIMI	glucagon	0002-6145	DODECYLPHOSPHOCHOLINE
>Company	>Tradename	>Ingredient	>NDC	>Excipient	>Potential Generic Entry

Detailed excipient profiles for glucagon

Excipient focus: ACETIC ACID

glucagon drug variants containing ACETIC ACID

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
Eli Lilly and Company	glucagon	0002-6145
Amphastar Pharmaceuticals Inc	glucagon	0548-8351
>Company	>Ingredient	>NDC

glucagon drug variants not containing ACETIC ACID

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
Fresenius Kabi USA LLC	glucagon	63323-596
Xeris Pharmaceuticals Inc	glucagon injection, solution	72065-130
>Company	>Ingredient	>NDC

Excipient focus: BETADEX

glucagon drug variants containing BETADEX

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
Eli Lilly and Company	glucagon	0002-6145
Amphastar Pharmaceuticals Inc	glucagon	0548-8351
>Company	>Ingredient	>NDC

glucagon drug variants not containing BETADEX

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
Fresenius Kabi USA LLC	glucagon	63323-596
Xeris Pharmaceuticals Inc	glucagon injection, solution	72065-130
>Company	>Ingredient	>NDC

Excipient focus: DIMETHYL SULFOXIDE

glucagon drug variants containing DIMETHYL SULFOXIDE

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
Xeris Pharmaceuticals Inc	glucagon injection, solution	72065-130
>Company	>Ingredient	>NDC

glucagon drug variants not containing DIMETHYL SULFOXIDE

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
Eli Lilly and Company	glucagon	0002-6145
Amphastar Pharmaceuticals Inc	glucagon	0548-8351
Fresenius Kabi USA LLC	glucagon	63323-596
>Company	>Ingredient	>NDC

Excipient focus: DODECYLPHOSPHOCHOLINE

glucagon drug variants containing DODECYLPHOSPHOCHOLINE

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
Eli Lilly and Company	glucagon	0002-6145
Amphastar Pharmaceuticals Inc	glucagon	0548-8351
>Company	>Ingredient	>NDC

glucagon drug variants not containing DODECYLPHOSPHOCHOLINE

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
Fresenius Kabi USA LLC	glucagon	63323-596
Xeris Pharmaceuticals Inc	glucagon injection, solution	72065-130
>Company	>Ingredient	>NDC

Excipient focus: HYDROCHLORIC ACID

glucagon drug variants containing HYDROCHLORIC ACID

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
Fresenius Kabi USA LLC	glucagon	63323-596
>Company	>Ingredient	>NDC

glucagon drug variants not containing HYDROCHLORIC ACID

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
Eli Lilly and Company	glucagon	0002-6145
Amphastar Pharmaceuticals Inc	glucagon	0548-8351
Xeris Pharmaceuticals Inc	glucagon injection, solution	72065-130
>Company	>Ingredient	>NDC

Excipient focus: LACTOSE MONOHYDRATE

glucagon drug variants containing LACTOSE MONOHYDRATE

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
Fresenius Kabi USA LLC	glucagon	63323-596
>Company	>Ingredient	>NDC

glucagon drug variants not containing LACTOSE MONOHYDRATE

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
Eli Lilly and Company	glucagon	0002-6145
Amphastar Pharmaceuticals Inc	glucagon	0548-8351
Xeris Pharmaceuticals Inc	glucagon injection, solution	72065-130
>Company	>Ingredient	>NDC

Excipient focus: SODIUM HYDROXIDE

glucagon drug variants containing SODIUM HYDROXIDE

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
Fresenius Kabi USA LLC	glucagon	63323-596
>Company	>Ingredient	>NDC

glucagon drug variants not containing SODIUM HYDROXIDE

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
Eli Lilly and Company	glucagon	0002-6145
Amphastar Pharmaceuticals Inc	glucagon	0548-8351
Xeris Pharmaceuticals Inc	glucagon injection, solution	72065-130
>Company	>Ingredient	>NDC

Excipient focus: SULFURIC ACID

glucagon drug variants containing SULFURIC ACID

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
Xeris Pharmaceuticals Inc	glucagon injection, solution	72065-130
>Company	>Ingredient	>NDC

glucagon drug variants not containing SULFURIC ACID

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
Eli Lilly and Company	glucagon	0002-6145
Amphastar Pharmaceuticals Inc	glucagon	0548-8351
Fresenius Kabi USA LLC	glucagon	63323-596
>Company	>Ingredient	>NDC

Excipient focus: WATER

glucagon drug variants containing WATER

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
Eli Lilly and Company	glucagon	0002-6145
Amphastar Pharmaceuticals Inc	glucagon	0548-8351
>Company	>Ingredient	>NDC

glucagon drug variants not containing WATER

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
Fresenius Kabi USA LLC	glucagon	63323-596
Xeris Pharmaceuticals Inc	glucagon injection, solution	72065-130
>Company	>Ingredient	>NDC

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.